During the Huawei Global Mobile Broadband Forum (MBBF) 2023, the concept of small box, big power and bigger business was presented via the LampSite solution.

Pin It
Read more: LampSite X: Small box, big power, bigger business

During the Broadband Africa Forum 2023, Telecom Review conducted an interview with Gary Lu, President of Network Marketing and Solutions Sales at Huawei. The host, Mathew Reed, Chief Analyst of Service Provider Markets at Omdia, led a discussion on broadband development in Africa, all-optical development in Africa, and other interesting topics.

Pin It
Read more: All-Optical Revolution: Transforming Broadband in Africa

In the ever-evolving world of telecommunications, the race towards 5G technology has become the central focus for industry leaders and innovators. At the heart of this transformation are the concepts of GigaGreen, that seek to revolutionize the way we experience 5G connectivity. Fang Xiang, Vice President of Huawei's Wireless Network Product Line, sat down for an exclusive interview with Telecom Review to discuss the company's groundbreaking all bands evolution to 5G and the next-gen GigaGreen series of solutions designed to build best 5G networks.

Pin It
Read more: Tech Breakthroughs Behind GigaGreen: Paving the Way for Best 5G Network

Notes from the Chief Editor

On October 1st, Health Canada approved the use of ID NOW rapid COVID-19 testing device— a move that could result in millions more tests for communities grappling with a surge in coronavirus cases.

The Abbott Laboratories-backed point-of-care devices can be administered by trained professionals at places like pharmacies, walk-in clinics and doctors' offices without the need for a laboratory to determine if someone is infected with the virus.

The approval comes only a day after the federal government announced that it would buy some 7.9 million ID NOW tests from the U.S.-based firm for distribution in Canada.

Moreover, Air Canada received the approval of Health Canada for a rapid test for passengers using Abott portal ID machine (2.99Kgs), which can give result in an average of 15 minutes or less starting with crew and volunteers to continue with passengers. This can limit the impact airlines have been having on their profitability due to COVID-19.

ID is using isothermal technology, proprietary enzymes and constant temperature control to achieve the fastest available RNA amplification. This proven molecular system greatly reduces the time for results. ID NOW is one of the most widely-available molecular point-of-care testing technologies in use in the U.S. Since its introduction in 2014, it has been used in physicians' offices to rapidly detect influenzas A & B, strep A, and respiratory syncytial virus (RSV).

Pin It